Iovance Biotherapeutics(IOVA) - 2020 Q1 - Quarterly Report

Table of Contents U. S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 For the transition period from to . Commission File Number 001-36860 IOVANCE BIOTHERAPEUTICS, INC. (Exact name of issuer as specified in its charter) Delaware 75-3254381 (State or other jurisdiction of (I.R.S. employer incorporation or organization) identification number) 999 Skyway Road, Suite 150, San Carlos, CA 94070 (Address of principal executive offices and zip code) (650) 260-7120 ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 ...